menu search

Cognition therapeutics invited to participate on panel during cantor fitzgerald brain week 2023 on novel alzheimer’s disease approaches

PURCHASE, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today...

June 20, 2023, 11:30 am

Fda panel endorses updating covid jab to target xbb strain

An FDA panel unanimously recommends updating COVID vaccines to target one of the currently dominating X...

June 16, 2023, 1:05 pm

Altimmune to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest on tuesday, june 20th, 2023

GAITHERSBURG, Md., June 16, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that D...

June 16, 2023, 7:30 am

Energy secretary granholm says she failed to reveal stock holdings; gop calls for investigation

WASHINGTON — The top Republican on the Senate Energy panel is calling for an investigation of Energy ...

June 14, 2023, 7:43 pm

Precipio’s omnia™ methodology enables diagnosis of mds with peripheral blood instead of bone marrow biopsy

Use of HemeScreen® technology enables diagnosis without the need for painful, invasive sampling NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) — ...

June 14, 2023, 1:49 pm

Aptamer surges on breakthrough in development of alzheimer's early diagnosis test

Aptamer Group PLC (AIM:APTA) shares surged over 200% higher in morning trade after the firm and Neuro-Bio, an Oxford-based biotech, announced a break...

June 14, 2023, 4:19 am

Inspirato to participate at the 2023 cantor fitzgerald technology conference

DENVER, June 12, 2023 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the innovative luxury travel ...

June 12, 2023, 8:30 pm

Futures rise as focus shifts to inflation data, fed meet

U.S. stock index futures rose on Monday ahead of inflation data and the Federal Reserve’s interest rate decision this week, while Biogen shares gain...

June 12, 2023, 3:44 pm

Biogen (biib), eisai alzheimer drug gets fda panel endorsement

An FDA advisory committee supports granting full approval to Biogen (BIIB)/Eisai's Alzheimer's disease antibody. NASDAQ halts BIIB's common stock trad...

June 12, 2023, 10:28 am

Biogen shares rise on imminent approval of alzheimer's drug following fda panel vote

Biogen Inc (NASDAQ:BIIB) shares rose in pre-market trading on Monday after a Food and Drug Administration (FDA) ...

June 12, 2023, 8:46 am

American battery technology company invited to present at battery metals and recycling focused investor conferences

RENO, Nev. , June 12, 2023 /PRNewswire/ -- American Battery Technology Company (ABTC) (OTCQX: ABML), an American critical battery materials company t...

June 12, 2023, 7:33 am

Biogen rises as fda panel backs alzheimer's drug, easing safety concerns

Shares of Biogen Inc rose 4% in premarket trade on Monday as an unanimous backing of the company's Alzheimer's drug Leqembi by the U.S. regulator's ad...

June 12, 2023, 6:26 am

Japan ppi (may) -0.7% m/m (expected -0.2%)

Japan PPI, AKA Corporate Goods Price Index. This is 'wholesale' level inflation, the price that firms charge each other for products.PPI -0.7% m/mexpe...

June 11, 2023, 11:50 pm

Biogen inches closer to fda approval for its alzheimer's drug

Shares of Biogen Inc (NASDAQ: BIIB) gained nearly 10% in extended hours after the biotech firm edged closer to winning FDA approval for its Alzheimer'...

June 10, 2023, 2:33 pm

: biogen stock rallies after full-day halt as fda panel recommends alzheimer’s drug for approval

Biogen Inc. BIIB shares rallied in the extended session late Friday following a full-day halt after the biotech company received a recommendation from...

June 9, 2023, 11:27 pm

Biogen stock rallies after full-day halt as fda panel recommends alzheimer's drug for approval

Biogen Inc. BIIB, +1.31% shares rallied in the extended session late Friday following a full-day halt after the biotech company received a recommendat...

June 9, 2023, 7:27 pm

Fda panel endorses astrazeneca (azn), sanofi's rsv antibody

The FDA's AMDAC unanimously recommends AstraZeneca (AZN)/Sanofi's (SNY) nirsevimab as full immunization against RSV disease for all infants....

June 9, 2023, 2:58 pm

Biogen stock halted as it faces make-or-break moment for alzheimer's treatment

Biogen stock was halted Friday as a panel of experts to the FDA debated the merits of its Alzheimer's t...

June 9, 2023, 2:29 pm

Remx: rare earth metals boom rolls on

The alternative energy revolution is driving demand for rare earth elements used in technologies like electric vehicles, wind turbines, and solar pane...

June 9, 2023, 8:44 am

Fda panel to debate us approval for alzheimer's drug from eisai and biogen

A panel of experts on Friday will discuss whether to recommend traditional U.S. regulatory approval for...

June 9, 2023, 7:04 am


Search within

Pages Search Results: